Clinical trial
Minocycline and Matrix Metalloproteinase Inhibition in Acute Intracerebral Hemorrhage: A Pilot Trial
NCT03040128 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minocycline and Matrix Metalloproteinase Inhibition in Acute Intracerebral Hemorrhage: A Pilot Trial
- Lead sponsor
- University of Tennessee
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 27, 2013
- Completion date
- November 30, 2016
- Enrollment
- 20 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral hemorrhage